Literature DB >> 33893191

Not Yet Time to Abandon the Deauville Criteria in Diffuse Large B-Cell Lymphoma.

Sally F Barrington1, Jakoba J Eertink, Henrika C W de Vet, N George Mikhaeel, Otto S Hoekstra, Josee M Zijlstra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33893191      PMCID： PMC8612338          DOI： 10.2967/jnumed.121.262317

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   11.082


× No keyword cloud information.
  9 in total

1.  Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.

Authors:  Mark Hertzberg; Maher K Gandhi; Judith Trotman; Belinda Butcher; John Taper; Amanda Johnston; Devinder Gill; Shir-Jing Ho; Gavin Cull; Keith Fay; Geoff Chong; Andrew Grigg; Ian D Lewis; Sam Milliken; William Renwick; Uwe Hahn; Robin Filshie; George Kannourakis; Anne-Marie Watson; Pauline Warburton; Andrew Wirth; John F Seymour; Michael S Hofman; Rodney J Hicks
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

2.  Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.

Authors:  Luca Ceriani; Maurizio Martelli; Maria K Gospodarowicz; Umberto Ricardi; Andrés J M Ferreri; Annalisa Chiappella; Caterina Stelitano; Monica Balzarotti; Maria E Cabrera; David Cunningham; Attilio Guarini; Pier Luigi Zinzani; Luca Giovanella; Peter W M Johnson; Emanuele Zucca
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-28       Impact factor: 7.038

3.  Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study.

Authors:  Sally F Barrington; Elizabeth H Phillips; Nicholas Counsell; Barry Hancock; Ruth Pettengell; Peter Johnson; William Townsend; Dominic Culligan; Bilyana Popova; Laura Clifton-Hadley; Andrew McMillan; Peter Hoskin; Michael J O'Doherty; Tim Illidge; John Radford
Journal:  J Clin Oncol       Date:  2019-05-21       Impact factor: 44.544

4.  Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients.

Authors:  J J Eertink; C N Burggraaff; M W Heymans; U Dührsen; A Hüttmann; C Schmitz; S Müller; P J Lugtenburg; S F Barrington; N G Mikhaeel; R Carr; S Czibor; T Györke; L Ceriani; E Zucca; M Hutchings; L Kostakoglu; A Loft; S Fanti; S E Wiegers; S Pieplenbosch; R Boellaard; O S Hoekstra; J M Zijlstra; H C W de Vet
Journal:  Blood Adv       Date:  2021-05-11

5.  Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.

Authors:  Anne-Ségolène Cottereau; Annibale Versari; Annika Loft; Olivier Casasnovas; Monica Bellei; Romain Ricci; Stéphane Bardet; Antonio Castagnoli; Pauline Brice; John Raemaekers; Bénédicte Deau; Catherine Fortpied; Tiana Raveloarivahy; Emelie Van Zele; Loic Chartier; Thierry Vander Borght; Massimo Federico; Martin Hutchings; Umberto Ricardi; Marc Andre; Michel Meignan
Journal:  Blood       Date:  2018-02-01       Impact factor: 22.113

6.  (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.

Authors:  Karen Juul Mylam; Lale Kostakoglu; Martin Hutchings; Morton Coleman; Dominick Lamonica; Myron S Czuczman; Louis F Diehl; Anne L Nielsen; Paw Jensen; Annika Loft; Helle W Hendel; Victor Iyer; Sirpa Leppä; Sirkku Jyrkkiö; Harald Holte; Mikael Eriksson; Dorte Gillstrøm; Per B Hansen; Marko Seppänen; Karin Hjorthaug; Peter de Nully Brown; Lars M Pedersen
Journal:  Leuk Lymphoma       Date:  2014-11-20

7.  FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study.

Authors:  N George Mikhaeel; David Cunningham; Nicholas Counsell; Andrew McMillan; John A Radford; Kirit M Ardeshna; Anthony Lawrie; Paul Smith; Laura Clifton-Hadley; Michael J O'Doherty; Sally F Barrington
Journal:  Br J Haematol       Date:  2020-07-04       Impact factor: 6.998

8.  Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.

Authors:  David M Kurtz; Florian Scherer; Michael C Jin; Joanne Soo; Alexander F M Craig; Mohammad Shahrokh Esfahani; Jacob J Chabon; Henning Stehr; Chih Long Liu; Robert Tibshirani; Lauren S Maeda; Neel K Gupta; Michael S Khodadoust; Ranjana H Advani; Ronald Levy; Aaron M Newman; Ulrich Dührsen; Andreas Hüttmann; Michel Meignan; René-Olivier Casasnovas; Jason R Westin; Mark Roschewski; Wyndham H Wilson; Gianluca Gaidano; Davide Rossi; Maximilian Diehn; Ash A Alizadeh
Journal:  J Clin Oncol       Date:  2018-08-20       Impact factor: 44.544

9.  Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method.

Authors:  Jan Rekowski; Andreas Hüttmann; Christine Schmitz; Stefan P Müller; Lars Kurch; Jörg Kotzerke; Christiane Franzius; Matthias Weckesser; Frank M Bengel; Martin Freesmeyer; Andreas Hertel; Thomas Krohn; Jens Holzinger; Ingo Brink; Uwe Haberkorn; Fonyuy Nyuyki; Daniëlle M E van Assema; Lilli Geworski; Dirk Hasenclever; Karl-Heinz Jöckel; Ulrich Dührsen
Journal:  J Nucl Med       Date:  2020-05-08       Impact factor: 10.057
  9 in total
  1 in total

1.  Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study.

Authors:  Zhen-Chong Yang; Ying-Ying Hu; Li-Ting Liu; Shan-Shan Guo; Chao-Chao Du; Yu-Jing Liang; Qiu-Yan Chen; Hai-Qiang Mai
Journal:  Eur Radiol       Date:  2022-05-04       Impact factor: 5.315
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.